Afshar-Oromieh A

References (2)

Title : Tailoring Fibroblast-Activation Protein Targeting for Theranostics: A Comparative Preclinical Evaluation of the (68)Ga- and (177)Lu-Labeled Monomeric and Dimeric Fibroblast-Activation Protein Inhibitors DOTA.SA.FAPi and DOTAGA.(SA.FAPi)(2) - Lappchen_2024_Molecules_29_
Author(s) : Lappchen T , Bilinska A , Pilatis E , Menendez E , Imlimthan S , Moon ES , Afshar-Oromieh A , Rosch F , Rominger A , Gourni E
Ref : Molecules , 29 : , 2024
Abstract :
PubMedSearch : Lappchen_2024_Molecules_29_
PubMedID: 38999044

Title : New Frontiers in Cancer Imaging and Therapy Based on Radiolabeled Fibroblast Activation Protein Inhibitors: A Rational Review and Current Progress - Imlimthan_2021_Pharmaceuticals.(Basel)_14_
Author(s) : Imlimthan S , Moon ES , Rathke H , Afshar-Oromieh A , Rosch F , Rominger A , Gourni E
Ref : Pharmaceuticals (Basel) , 14 : , 2021
Abstract :
PubMedSearch : Imlimthan_2021_Pharmaceuticals.(Basel)_14_
PubMedID: 34681246
Gene_locus related to this paper: human-FAP